Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease

Clinical trial NCT02540993 · COMPLETED

Trial details

NCT number: NCT02540993
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Disease

Start date: 2015-09-17
Primary completion: 2020-04-14
Enrollment: 5734

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.